FDA Approves Menactra for Meningococcal Disease, Sanofi pasteur

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the US Food and Drug Administration (FDA) has licensed Menactra(TM) (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years......

Continue to FDA Approves Menactra for Meningococcal Disease, Sanofi pasteur on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz